> In clinical studies for the treatment of visual impairment due to DME, the outcome with regard to visual acuity or central RETINAL subfield thickness (CSFT ) in patients treated with LUCENTIS was not affected by concomitant treatment with THIAZOLIDINEDIONES. 
